TrialOncotarget2010

Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.

Emmanuel Raffoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.